title: [Dynamics of leukocytes' migration degree in oral cavity and parameters of INFgamma and TNFalpha in blood serum of patients suffering from parodontitis on the background of treatment with Unimag].
abstract: In the oral cavity of patients with parodontitis before treatment the quantity of migrated leukocytes (ML) was increased. Among them number of living cells was sharply reduced. In the process of treatment on the background of immune modulation with Unimag, the concentration of migrated leukocytes decreases and number of living leukocytes increases. The above-mentioned quantitative and qualitative parameters of migrated leukocytes were normalized after 1-1.5 months. The analogical dynamics has been detected in patients suffering from parodontitis and treated with traditional scheme. However, despite reduced concentration of migrated leukocytes and increased percentage of living leukocytes' content, normalization of the mentioned parameters has not been detected. In the blood serum of patients suffering from parodontitis increased concentration of INFgamma and TNFalpha have been revealed. In the process of treatment, concentration of the mentioned cytokines was decreased, however, in patients treated with Unimag on the background of immune modulation, decrease in concentration of INFgamma and TNFalpha was much more expressed.
authors.forename: M G
authors.initials: MG
authors.lastname: Saralidze
authors.forename: L M
authors.initials: LM
authors.lastname: Dzhashi
authors.forename: T G
authors.initials: TG
authors.lastname: Tskitishvili
authors.forename: N N
authors.initials: NN
authors.lastname: Gogebashvili
authors.forename: B V
authors.initials: BV
authors.lastname: Surguladze
mesh_terms: D002634:Chemotaxis, Leukocyte / Q000187:drug effects*; D004797:Enzyme-Linked Immunosorbent Assay; D052203:Ferrosoferric Oxide / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology / Q000627:therapeutic use*; D007371:Interferon-gamma / Q000097:blood*; D009055:Mouth / Q000187:drug effects*; D010510:Periodontal Diseases / Q000097:blood* / Q000628:therapy*; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
chemical_list: D007155:Immunologic Factors; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma; D052203:Ferrosoferric Oxide